Recruiting nowNot applicable
The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region
Updated 2025-05-08 · NCT06561529See eligibility →
Country
Active obesity and GLP-1 studies with at least one location in Latvia.
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.